-
Amarzguioui M, Prydz H. An algorithm for selection of functional siRNA sequences[J]. Biochem Biophys Res Commun, 2004, 316(): 1050-1058. doi: 10.1016/j.bbrc.2004.02.157
-
Arvelo M B, Cooper J T, Longo C. A20 protects mice from D-galacto-samine/lipopolysaccharide acute toxic lethal hepatitis[J]. Hepatology, 2002, 35(): 535-543. doi: 10.1053/jhep.2002.31309
-
Ding J W, Ning Q, Liu M F. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase[J]. J Virol, 1997, 71(): 9223-9230.
-
Hecht N, Pappo O, Shouval D. Axelrod JH.Hyper-IL-6 gene therapy reverses fulminant hepatic failure[J]. Mol Ther, 2001, 3(): 683-687. doi: 10.1006/mthe.2001.0313
-
Huesken D, Lange J, Mickanin C. Design of a genome-wide siRNA library using an artificial neural network[J]. Nat Biotechnol, 2005, 23(): 995-1001. doi: 10.1038/nbt1118
-
Khvorova A, Reynolds A, Jayasena S D. Functi-onal siRNAs and miRNAs exhibit strand bias[J]. Cell, 2003, 115(): 209-216. doi: 10.1016/S0092-8674(03)00801-8
-
Kim D H, Behlke M A, Rose S D. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy[J]. Nat Biotechnol, 2005, 23(): 222-226. doi: 10.1038/nbt1051
-
Levy G A, Liu M, Ding J. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis[J]. Am J Pathol, 2000, 156(): 1217-. doi: 10.1016/S0002-9440(10)64992-9
-
Li C, Fung L S, Chung S. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection[J]. J Exp Med, 1992, 176(): 689-697. doi: 10.1084/jem.176.3.689
-
Marsden P A, Ning Q, Fung L S. The Fgl2/fibroleukin prothrombinase contributes to immu-nologically-mediated thrombosis in experimental and human viral hepatitis[J]. J Clin Inves, 2003, 112(): 58-66. doi: 10.1172/JCI18114
-
Nakayama Y, Shimizu Y, Hirano K. Sugiyama T CTLA-4Ig suppresses liver injury by inhi-biting acquired immune responses in a mouse model of fulminant hepatitis[J]. Hepatology, 2005, 42(): 915-924. doi: 10.1002/hep.v42:4
-
Ning Q, Brown D, Parodo J. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response[J]. J Immunol, 1998, 160(): 3487-3493.
-
Reynolds A, Leake D, Boese Q. Rational siRNA design for RNA interference[J]. Nat Biotechnol, 2004, 22(): 326-330. doi: 10.1038/nbt936
-
Schwarz D S, Hutvagner G, Du T. Asymmetry in the assembly of the RNAi enzyme complex[J]. Cell, 2003, 115(): 199-208. doi: 10.1016/S0092-8674(03)00759-1
-
Song E, Lee SK, Wang J. RNA interference targeting Fas protects mice from fulminant hepatitis[J]. Nat Med, 2003, 8(): 347-351.
-
Ui-Tei K, Naito Y, Takahashi F. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference[J]. Nucleic Acids Res, 2004, 32(): 936-948. doi: 10.1093/nar/gkh247
-
Zhu C L, Sun Y, Luo X P. Novel mfgl2 antisense plasmid inhibits mfgl2 expression and ameli-orates MHV-3 induced fulminant hepatitis in Balb/cJ mice[J]. Human Gene Therapy, 2006, 17(): 589-600. doi: 10.1089/hum.2006.17.589